Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Giant Cell Arteritis and Takayasu's Arteritis
NCT00556439Phase 2Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Dec 2008
- Primary completion
- Aug 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of abatacept in giant cell arteritis (GCA), Takayasu's arteritis (TAK), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Dec 2008; status: completed.
02
Drugs
abatacept
03
Conditions
giant cell arteritis (GCA)Takayasu's arteritis (TAK)
Beyond the preview
Go deeper on NCT00556439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556439.